Case #668

Separating short therapy diabetes cases from DRG 910O

Added by Elina Hermiö 8 months ago. Updated 6 months ago.

Status:AcceptedStart date:2020-01-27
Priority:MinorSpent time:-
Target version:-
Initiator:Finland Target year:2021
Case type: Owner / responsible:
MDC: Old forum status:
Target Grouper:FIN, ICE


Currently the short therapy diabetes cases are grouped in Finnish version into DRG 910O Endocrine, nutritional and metabolic disease or disorder, short therapy w/o significant procedure. Given the burden diabetes gives to health care systems and bearing in mind the importance of follow-up of diabetes patients, Finland would like to have clinically meaningful group for outpatient diabetes patients and separate the cases from other cases in DRG 910O.
This change follows the changes which have been made already earlier in Swedish and Norwegian version.

For analysis, the data of five Finnish university was used from year 2018.
The analysis shows that there is no significant difference in mean cost of 259O and 910O cases (14% without trimming, and 6% after 1% trimming). However, the clinical meaningfulness plays more important role in that change.
In both groups the V% improves significantly after 1% trimming (in DRG 295O 111%->66% and in DRG 910 194%->79%)

Based on the analysis, we suggest introducing DRG 295O for short therapy diabetes cases also into Finnish version.

DRG change
After the suggested changes the short therapy diabetes cases previously grouped into DRG 910O will be grouped into DRG 295O Diabetes, short therapy. In definition tables, new rule (124D2010002) will be added above the current rule (110D109960) of DRG 910O.

Cost analysis
Appendix 1. Cost analysis is based on five university hospitals’ data of year 2018, grouped with FIN 2020PR1 grouper.

Technical changes
Appendix 2.

FIN_5.1-Appendix1.Diabetes_short_therapy_DRG_295O.xlsx (10.3 KB) Elina Hermiö, 2020-01-27 14:13

FIN_5.2-Appendix2.Diabetes_short_therapy_DRG_295O.xlsx (16.3 KB) Elina Hermiö, 2020-01-27 14:13

Tabell910.JPG (51.9 KB) Kristin Dahlen, 2020-03-06 16:22

TC_668_Diabetes_short_therapy.xlsx (16.4 KB) Kristiina Kahur, 2020-04-02 13:14

TC_668_Diabetes_short_therapy_2.xlsx (16.5 KB) Kristiina Kahur, 2020-04-14 11:17


#1 Updated by Kristin Dahlen 7 months ago

In the Norwegian version we have already made a split for DRG 910O. Instead of making a new DRG 295O, we simply made a split of DRG 910 into A, B, C and O.

#2 Updated by Martti Virtanen 7 months ago

  • Status changed from Active to Accepted

2020-03-09 Expert group
The proposed change was accepted for Finland (and for Norway). The changes will to extent possible use the same logic rules as existing Swedish model The DRG coding will obviously be different and that is taken care int the national DRGnames table.
The technical changes will be reported based on new NDMS.

#3 Updated by Kristiina Kahur 6 months ago

Nordic Casemix Centre/Kristiina Kahur 2-4-2020

This change concerns only Finland. The TC are updated.
Countries not having this change in there national version may inform us about adding it by April 9th.

#4 Updated by Birna Björg Másdóttir 6 months ago

Iceland would also like to separate the short therapy diabetes cases from DRG 910O and create a new DRG 295O for those cases.

The Icelandic name for 295O - Sykursýki, stutt meðferð

#5 Updated by Kristiina Kahur 6 months ago

Nordic Casemix Centre/Kristiina Kahur, 14-4-2020

Based on the feedback after the expert group meeting, this change is implemented ICE and FIN 2021 tables.
TC have been updated and attached.

Also available in: Atom PDF